Table 1.
Setting | Clinical Outcomes | Cardiovascular Outcomes |
---|---|---|
Adjuvant | ||
Breast | ↓ CVD events22 | ↑23 ↔24 ↓25 CRF |
↓ CAD mortality22 | ↓ LVEF26 | |
Prostate | ↑ CRF27 | |
Colorectal | ↑ CRF | |
Mixed (meta-analysis) | ↑ CRF21 | |
Postadjuvant | ||
Breast | ↓ CVD events28 | ↔ ↑ CRF |
↓ All-cause mortality29 | ↑ Vascular function | |
Prostate | ↑ CRF30 | |
↑ Vascular function30 | ||
↔ Lipid profile30 | ||
↔ Blood pressure30 | ||
ASCC | ↓ CVD events31 | |
↓ All-cause mortality31 | ||
Testicular | ↑ CRF32 | |
↑ Vascular function32 | ||
↑ Framingham Risk Score32 | ||
Colorectal | ↓ All-cause mortality29 | ↑33 ↔34 CRF |
Leukemia | ↑ CRF35 | |
Lymphoma | ↑ CRF36 | |
Mixed (meta-analysis) | ↑ CRF21 |
Downward-pointing arrow (↓) indicates a decrease; upward-pointing arrow (↑) indicates an increase; and sideways-pointing arrow (↔) indicates no change. ASCC indicates adult survivors of childhood cancer; CAD, coronary artery disease; CRF, cardiorespiratory fitness; CVD, cardiovascular disease; and LVEF, left ventricle ejection fraction.